Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S MOTRIN versus MECLOFENAMATE SODIUM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S MOTRIN versus MECLOFENAMATE SODIUM.
CHILDREN'S MOTRIN vs MECLOFENAMATE SODIUM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, thereby decreasing pain, fever, and inflammation.
Meclofenamate sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), thereby reducing prostaglandin synthesis, which mediates inflammation, pain, and fever.
200-400 mg orally every 6-8 hours as needed; maximum 1200 mg/day without prescription, extended release forms: 600-800 mg orally twice daily.
50 mg or 100 mg orally three times daily; maximum 400 mg/day.
None Documented
None Documented
2-4 hours in children; prolonged in neonates and hepatic impairment.
2-4 hours (terminal half-life; may be prolonged in hepatic impairment or elderly)
Renal (90%) as inactive metabolites and conjugates; fecal (<5%).
Renal (60-70% as metabolites and conjugates), biliary/fecal (20-30%)
Category C
Category C
NSAID
NSAID